Could not have put it better myself. In my view its gone from a beauty queen to an ugly ducking which then morphed into a dog and today I would call it a dog of a stock with fleas. And I note today another biotech company announced it was running clinical trials overseas... where, in India, covid related trials admittedly but still, it shows ASX biotech companies are prepared to go elsewhere for recruiting cohorts, recently one underway in Japan with a Japanese partner and before that another I recall ran trials in Eastern Europe due lower costs and faster recruitment. I hope to high heaven our management have Plan B if required that embraces recruitment somewhere else other than Oz, In fact I just hope we have a Plan B, full stop.
IBX Price at posting:
6.5¢ Sentiment: Hold Disclosure: Held
